Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spontaneously remitting dermatomyositis.

J R Jordan1, S Paruthi, R O Pichardo

  • 1Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA.

Journal of the European Academy of Dermatology and Venereology : JEADV
|June 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis.

Skin health and disease·2021
Same author

Gentian violet for pyoderma gangrenosum: a retrospective chart review.

Dermatology online journal·2020
Same author

Depression in hidradenitis suppurativa.

The British journal of dermatology·2019
Same author

Even mild hidradenitis suppurativa impairs quality of life.

The British journal of dermatology·2019
Same author

First Measurement of Monoenergetic Muon Neutrino Charged Current Interactions.

Physical review letters·2018
Same author

Does daily folic acid supplementation reduce methotrexate efficacy?

Dermatology online journal·2018
Same journal

Environmental criteria in dermatology research grants.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Microneedling with adipose MSC exosomes versus monotherapy for androgenetic alopecia.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Diabetes and melanoma: Impact on prognosis and healthcare costs.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Differential survival with adjuvant immunotherapy in stage III acral versus non-acral melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Estimating the global burden of mental health disorders associated with atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Proteomic analysis in hidradenitis suppurativa reveals systemic inflammation in all disease stages.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
See all related articles

This case study presents a unique patient with normal-enzyme dermatomyositis (DM) who experienced skin improvement with topical therapy and no muscle weakness progression, despite initial EMG and biopsy findings. This challenges typical disease progression, offering new insights into inflammatory myopathies.

Area of Science:

  • Rheumatology
  • Dermatology
  • Neurology

Background:

  • Dermatomyositis (DM) is a rare inflammatory myopathy characterized by muscle and skin inflammation.
  • Normal-enzyme DM presents with skin findings but normal muscle enzyme levels, typically progressing to significant muscle weakness.

Observation:

  • A patient with normal-enzyme DM showed histological and electromyography (EMG) evidence of muscle involvement.
  • Unlike typical cases, this patient did not develop progressive muscle weakness.

Findings:

  • Topical therapy led to near-complete resolution of cutaneous manifestations within one year.
  • Despite initial diagnostic findings, the patient maintained no muscle weakness throughout the observation period.

Implications:

Related Experiment Videos

  • This case suggests that some patients with normal-enzyme DM may not follow the typical progressive weakness course.
  • The findings highlight the potential for spontaneous or treatment-assisted resolution of muscle involvement in specific DM cases.
  • Further research is warranted to understand the mechanisms behind this atypical disease course and explore novel therapeutic strategies.